Naloxone HCl Dihydrate

• CAT Number: A000111
• CAS Number: 51481-60-8
• Molecular Formula: C19H26ClNO6
• Molecular Weight: 399.87
• Purity: ≥95%
• Storage: 2-8°C
• IUPAC Name: (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;dihydrate;hydrochloride
• InChI: InChI=1S/C19H21NO4.ClH.2H2O/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11;;;/h2-4,14,17,21,23H,1,5-10H2;1H;2*1H2/t14-,17+,18+,19-;;;/m1.../s1
• InChIKey: TXMZWEASFRBVKY-IOQDSZRYSA-N
• SMILES: C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.O.O.Cl

Naloxone HCl dihydrate（Cat No.:A000111）, is a pharmaceutical compound used as an opioid receptor antagonist. It is a potent medication employed to counteract the effects of opioid overdose, particularly life-threatening respiratory depression. Naloxone works by rapidly binding to opioid receptors in the brain, displacing opioid molecules and reversing their effects. The inclusion of dihydrate indicates that the compound contains two water molecules in its crystal structure. Naloxone HCl dihydrate is commonly administered by healthcare professionals and emergency responders in cases of opioid overdose to restore normal breathing and prevent fatal outcomes, making it a critical tool in opioid overdose management.